David Tendler
Plus aucun poste en cours
Profil
David Tendler, who previously worked at New York Blood Center, Savient Pharmaceuticals, V.I.
Technologies, and Community Blood Center of Greater Kansas City, held director and chairman positions.
Anciens postes connus de David Tendler
| Sociétés | Poste | Fin |
|---|---|---|
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Directeur/Membre du Conseil | 11/03/2005 |
Community Blood Center of Greater Kansas City
 Community Blood Center of Greater Kansas City Medical/Nursing ServicesHealth Services Community Blood Center of Greater Kansas City operates blood distribution and research organizations. The company is based in Kansas City, MO. Community Blood Center of Greater Kansas City was acquired by New York Blood Center, Inc. on August 04, 2014. | Directeur/Membre du Conseil | - |
New York Blood Center, Inc.
 New York Blood Center, Inc. Medical/Nursing ServicesHealth Services New York Blood Center, Inc. operates blood distribution and research organizations. It provides blood and blood products for transfusions annually. The company was founded in 1964 and is located in New York, NY. | Président | - |
| SAVIENT PHARMACEUTICALS INC | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Vitex is a Delaware Corporation incorporated in 1995. Vitex’s scientific and clinical programs originated in anti-infective technologies designed to prevent the spread of infectious disease by blood transfusions. In March of 2005, Vitex merged with Panacos Pharmaceuticals, a private company developing HIV therapeutics with novel mechanisms of action. The merger with Panacos immediately expanded the Vitex pipeline into novel, high value therapeutics. The Panacos team that joined Vitex is recognized for fundamental contributions to HIV biology and drug development | Health Technology |
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services New York Blood Center, Inc. operates blood distribution and research organizations. It provides blood and blood products for transfusions annually. The company was founded in 1964 and is located in New York, NY. | Health Services |
Community Blood Center of Greater Kansas City
Community Blood Center of Greater Kansas City Medical/Nursing ServicesHealth Services Community Blood Center of Greater Kansas City operates blood distribution and research organizations. The company is based in Kansas City, MO. Community Blood Center of Greater Kansas City was acquired by New York Blood Center, Inc. on August 04, 2014. | Health Services |
